#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Neurofibroma Acute on chronic liver failure Neuroendocrine carcinoma metastatic Chronic hepatitis B Gastric cancer Canavan disease Kawasaki's disease Hereditary motor and sensory neuropathy Infertility female Angiosarcoma non-metastatic Lymphangiosarcoma Staphylococcal infection Hypertriglyceridaemia Obliterative bronchiolitis Hepatoblastoma More trials…
Learn about Rare Diseases

Hereditary neuropathic amyloidosis – Diagnostics Breast angiosarcoma – Diagnostics Gaucher’s disease type III – Treatment Niemann-Pick disease Rosai-Dorfman syndrome Carcinoid syndrome – Diagnostics Hereditary optic atrophy – Basic Information Marginal zone lymphoma Hereditary hypophosphataemic rickets – Life with Disease Haemophilia A without inhibitors – Treatment More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Dextran 70 Olanzapine Tapentadol Hydrochloride Meropenem Folic Acid Felzartamab Sodium Ascorbate Zongertinib Maribavir Lamotrigine Lavender Oil Ondansetron Sapropterin Dihydrochloride POTASSIUM CLAVULANATE 64CU-PSMA I&T Sacubitril ULVIPRUBART Palmidrol Tub-040 Doravirine More therapies…

Learn about Your Condition

HER2 negative breast cancer Sarcoidosis Burkitt's lymphoma Acromegaly Liposarcoma metastatic Angelman's syndrome Hand fracture Basal cell carcinoma Anal cancer Glomerulonephritis chronic Inflammatory bowel disease Endocarditis bacterial Rhabdoid tumour Gout Neurodermatitis More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Liposarcoma metastatic

Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

Recruiting

3 1 1
Investigated Drugs:
- Ttf-Ngr
Study of Pemigatinib and Retifanlimab for Patients with Advanced Dedifferentiated Liposarcoma

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Pemigatinib
- Retifanlimab
Study on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors

Not recruiting

2 1 1 1
Investigated Drugs:

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Liposarcoma metastatic

Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

Study of Pemigatinib and Retifanlimab for Patients with Advanced Dedifferentiated Liposarcoma

Study on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies